Earnings History Data for LifeMD, Inc. (LFMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

LifeMD, Inc.

LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-03-2024	AH		LFMD	LifeMD, Inc.	300.03	-0.12	-0.14	-0.40	LifeMD Non-GAAP EPS of $0.15 beats by $0.12, revenue of $44.86M beats by $4.37M [3/11/2024 4:27 PM]	8.38	0.42 (5.35%)	8.30	0.35 (4.40%)	1.14 - 9.11	2,263,082	600,000	93,059
LifeMD Non-GAAP EPS of $0.15 beats by $0.12, revenue of $44.86M beats by $4.37M [3/11/2024 4:27 PM]
08-11-2023	AH		LFMD	LifeMD, Inc.	263.40	-0.20	-0.18	-0.03	LifeMD, Inc. Non-GAAP EPS of $0.08 beats by $0.05, revenue of $38.6M beats by $0.43M [11/8/2023 4:59 PM]	6.84	-0.32 (-4.47%)	7.35	0.19 (2.65%)	1.14 - 7.77	1,456,066	500,000	19,852
LifeMD, Inc. Non-GAAP EPS of $0.08 beats by $0.05, revenue of $38.6M beats by $0.43M [11/8/2023 4:59 PM]
09-08-2023	AH		LFMD	LifeMD, Inc.	127.05	-0.23	-0.09	-0.22	LifeMD, Inc. Non-GAAP EPS of $0.05, revenue of $35.9M [8/9/2023 5:12 PM]	4.40	0.74 (20.22%)	3.90	0.24 (6.56%)	1.14 - 5.45	935,295	310,000	6,357
LifeMD, Inc. Non-GAAP EPS of $0.05, revenue of $35.9M [8/9/2023 5:12 PM]
12-05-2023	PM	Before the open (May 12)	LFMD	LifeMD, Inc.	55.80	-0.15	0.00	-0.25	LifeMD, Inc. Non-GAAP EPS of $0.06, revenue of $33M beats by $2.19M [5/12/2023 9:24 AM]	1.82	-0.01 (-0.55%)	1.88	0.05 (2.73%)	1.14 - 3.22	437,628	50,000	34,663
LifeMD, Inc. Q1 Earnings Preview [5/11/2023 12:49 PM] LifeMD, Inc. Non-GAAP EPS of $0.06, revenue of $33M beats by $2.19M [5/12/2023 9:24 AM]
22-03-2023	AH	4:05 PM ET (Mar 22)	LFMD	LifeMD, Inc.	58.18	-0.40	0.00	-0.29	LifeMD Non-GAAP EPS of $0.02, revenue of $28.12M misses by $5.46M [3/23/2023 2:17 PM]	1.45	0.05 (3.57%)	1.50	0.10 (7.14%)	1.14 - 3.89	434,520	210,000	61,461
LifeMD Non-GAAP EPS of $0.02, revenue of $28.12M misses by $5.46M [3/23/2023 2:17 PM]
10-11-2022	AH	4:05 PM ET (Nov 10)	LFMD	LifeMD, Inc.	64.07	-0.03	-0.27	-0.36	LifeMD Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $31.41M misses by $0.44M [11/10/2022 5:08 PM]	2.49	0.41 (19.61%)	2.00	-0.01 (-0.50%)	1.80 - 5.40	220,578	80,000	1,002
LifeMD Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $31.41M misses by $0.44M [11/10/2022 5:08 PM] LifeMD, Inc. Reports Third Quarter 2022 Results [Nov-10-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	LFMD	LifeMD, Inc.	72.06	-0.22	-0.23	-0.51	LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M [8/11/2022 5:50 PM]	2.90	-0.25 (-7.90%)	3.20	0.05 (1.59%)	1.80 - 9.25	321,376	140,000	12,438
LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M [8/11/2022 5:50 PM] LifeMD, Inc. Reports Second Quarter 2022 Results [Aug-11-22 04:05PM]
13-05-2022	PM	Before the open (May 13)	LFMD	LifeMD, Inc.	62.73	-0.25	-0.25	-0.38	LifeMD Non-GAAP EPS of -$0.25 beats by $0.01, revenue of $29M misses by $2.53M [5/13/2022 8:39 AM]	2.14	0.20 (10.31%)	2.10	0.16 (8.25%)	1.85 - 16.28	110,819	130,000	779
LifeMD Q1 2022 Earnings Preview [5/12/2022 12:24 PM] LifeMD Non-GAAP EPS of -$0.25 beats by $0.01, revenue of $29M misses by $2.53M [5/13/2022 8:39 AM] LifeMD, Inc. Reports First Quarter 2022 Results [May-13-22 07:30AM]
07-03-2022	AH	4:05 PM ET (Mar 7)	LFMD	LifeMD	103.00	-0.29	-0.39	0.00	LifeMD Non-GAAP EPS of -$0.29, revenue of $27.42M [3/7/2022 4:15 PM]	3.47	0.26 (8.10%)	3.20	-0.02 (-0.62%)	2.72 - 21.95	128,737	120,000	2,122
LifeMD Non-GAAP EPS of -$0.29, revenue of $27.42M [3/7/2022 4:15 PM] LifeMD Reports Fourth Quarter and Full Year 2021 Results [Mar-07-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	LFMD	LifeMD, Inc.	151.74	-0.36	-0.49	-1.65	LifeMD EPS beats by $0.26, misses on revenue [11/10/2021 4:21 PM]	4.83	-0.17 (-3.40%)	5.40	0.40 (8.00%)	4.50 - 33.02	669,405	370,000	15,356
LifeMD EPS beats by $0.26, misses on revenue [11/10/2021 4:21 PM] LifeMD Reports Q3 2021 Revenue Up 127% to Record $24.9 Million and 24% Sequential Improvement in Adjusted EBITDA [Nov-10-21 04:05PM]
12-08-2021	AH	4:00 PM ET (Aug 12)	LFMD	LifeMD, Inc.	248.53	-0.51	-0.45	-0.30	LifeMD EPS beats by $0.02, beats on revenue [8/12/2021 4:20 PM]	7.39	-1.72 (-18.88%)	8.02	-1.09 (-11.96%)	4.40 - 33.02	1,632,673	350,000	18,892
LifeMD EPS beats by $0.02, beats on revenue [8/12/2021 4:20 PM] LifeMD posts wider Q2 net loss, maintains FY revenue forecast [8/13/2021 11:17 AM] LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention [Aug-12-21 04:05PM]
13-05-2021	AH	4:05 PM ET (May 13)	LFMD	LifeMD, Inc.	183.42	-0.38	-0.44	-0.25	LifeMD EPS beats by $0.21, misses on revenue [5/13/2021 4:31 PM]	8.79	2.28 (35.02%)	7.30	0.79 (12.14%)	1.35 - 33.02	14,305,362	800,000	158,064
LifeMD EPS beats by $0.21, misses on revenue [5/13/2021 4:31 PM] LifeMD surges 11% as telemedicine provider achieves record revenue [5/14/2021 9:04 AM] LFMD INVESTOR ALERT: Shareholder Lawsuit Filed [May-12-21 12:30PM] Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeMD, Inc. (LFMD) [May-13-21 11:00AM] DEADLINE ALERT for LFMD, RMO, and CS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [May-13-21 12:05PM] LifeMD, Inc. to Host Earnings Call [May-13-21 02:30PM] LifeMD Reports Q1 2021 Revenue up 323% to Record $18.2M, Raises Full Year Revenue Guidance to $90-$100M [May-13-21 04:01PM] Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm [May-13-21 10:00PM]
29-03-2021	AH	After the close (Mar 29)	LFMD	LifeMD, Inc.	479.61	-2.56	-0.27	-0.05	LifeMD EPS of -$2.56 [3/29/2021 4:21 PM]	16.09	-2.78 (-14.73%)	17.25	-1.62 (-8.59%)	0.99 - 33.02	1,655,348	730,000	5,989
LifeMD EPS of -$2.56 [3/29/2021 4:21 PM] LifeMD, Inc. to Host Earnings Call [Mar-29-21 02:30PM] LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million [Mar-29-21 04:05PM]